Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemia.

C F LeMaistre; M G Rosenblum; J M Reuben; D R Parkinson; C M Meneghetti; K Parker; J P Shaw; A B Deisseroth; T Woodworth

doi:10.1016/0140-6736(91)92788-4

Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemia.

Identifier:nobleid.org/w1/20260515/B0BADBEE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B0BADBEE.svg?ark=w1%2F20260515%2FB0BADBEE)](https://nobleid.org/work/w1/20260515/B0BADBEE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemia.

Identifier:nobleid.org/w1/20260515/B0BADBEE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B0BADBEE.svg?ark=w1%2F20260515%2FB0BADBEE)](https://nobleid.org/work/w1/20260515/B0BADBEE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work